Search for

The morning of 14 December 2016 saw the official launch of the new Pharmacology Core Curriculum  by Dr Lisa Wallace and Professor Ian McFadzean, new and outgoing Vice Presidents Academic Development of the Society and Chairs of the Education and Training Committee, respectiv...

Sir William DM Paton Bill Paton, who was knighted in 1979 and was therefore sometimes addressed as Sir William (but never William), was a major figure in British pharmacology and the British Pharmacological Society (BPS). With Eleanor Zaimis, he played a seminal role in t...

Clinical trials are at the heart of modern medical research. They are the best means we have of testing whether a medicine is safe and whether it works. Around the world, pharmaceutical companies, universities, government research institutes and medical charities run tens of ...

Chronic pain is a serious and growing worldwide problem, and the burden it places on our society is increasing. To manage the symptoms associated with chronic pain there is heavy reliance on the use of opioid analgesics, although there are limited studies to support their ...

What a first day In December 2019, I received the call informing me that I had been successful in my application to join the BPS as its new CEO; cue huge excitement, anticipation, and lots of nerves! Fast forward 3 months to 16 March, my first day in the office. It soon...

Dr Jeffrey Aronson, honorary consultant physician and clinical pharmacologist, University of Oxford What do you do? and what is a typical week for you? I am attached to the Centre for Evidence Based Medicine in Oxford, working in tandem with academic general practitioners a...

In March 2019, the Society’s Council agreed the following principles for the Society’s approach to open science and open access.

Our response to the Royal Pharmaceutical Society (RPS) polypharmacy professional guidance consultation. Read the full response

SARS-CoV-2 is a new virus, causing a new disease, COVID-19. It is possible that existing anti-viral and immunomodulatory drugs may be able to be repurposed for treating COVID-19. However, there is no guarantee that a safe and effective treatment will be found immediately: the...